PharmaBoardroom

A Saviour for America’s Opioid Crisis?

Today the USA finds itself in the midst of an opioid crisis, claiming 40,000 American lives every year - a comparable death toll to the HIV epidemic…

M&A trends and activity in 2018

It has been a robust first half in 2018 within the life sciences sector for mergers and acquisition (M&A) and investment activities. Deal-tracking…

M&A by necessity: Takeda and Shire

The stakes are high, and the outcome is uncertain in one of the largest Pharma M&A deals ever. Takeda’s proposed acquisition of Shire seems…

Healthcare needs an overhaul, move it to blockchain

"Imagine a world where every single ingredient inside every single pharmaceutical you take is traced from start to finish." We can all agree that the…

José-Alain Sahel – Founder and Director, Institut de la…

Professor José-Alain Sahel, founder and director of the Institute de la Vision in Paris, offers his insider take on the ophthalmology landscape in…

Diversity, Inclusion and Addressing Unconscious Bias

Ai Hua Ong, Company Group Chairman, Asia Pacific, The Janssen Pharmaceutical Companies of Johnson & Johnson. There is a clear…

One Business or Two? The Era of Precision Medicine

In my career, I’ve held senior roles in both the biopharma and diagnostics sectors. Working across different cost structures, different business…

Stronger Together: Tackling the US/Canadian Opioid Epidemic

Article contributed by Carla Smith, Executive Vice President of The Healthcare Information and Management Systems Society (HIMMS) for PharmaBoardroom.…